Kraig Biocraft Laboratories Valuation

Is KBLB undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

0/6

Valuation Score 0/6

Below Fair Value
Significantly Below Fair Value
Price-To-Book vs Peers
Price-To-Book vs Industry
Price-To-Book vs Fair Ratio
Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of KBLB when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: Insufficient data to calculate KBLB's fair value for valuation analysis.

Significantly Below Fair Value: Insufficient data to calculate KBLB's fair value for valuation analysis.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for KBLB?

Key metric: As KBLB is unprofitable and pre-revenue we use its Price-To-Book Ratio for relative valuation analysis.

The above table shows the Price to Book ratio for KBLB. This is calculated by dividing KBLB's market cap by their current book value.
What is KBLB's PB Ratio?
PB Ratio	-7.4x
Book	-US$12.59m
Market Cap	US$90.55m

KBLB key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue	n/a
Enterprise Value/EBITDA	-27.4x
PEG Ratio	n/a

Price to Book Ratio vs Peers

How does KBLB's PB Ratio compare to its peers?

The above table shows the PB ratio for KBLB vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
Company	Forward PB	Estimated Growth	Market Cap
Peer Average	4.2x
LOOP Loop Industries	14.2x	63.5%	US$67.1m
CMT Core Molding Technologies	1x	1.6%	US$151.4m
ORGN Origin Materials	0.5x	22.2%	US$177.6m
GLGI Greystone Logistics	1.2x	n/a	US$27.7m
KBLB Kraig Biocraft Laboratories	n/a	n/a	US$90.5m

Price-To-Book vs Peers: KBLB has negative equity and a Price-To-Book Ratio (-7.4x) compared to the peer average (4.2x).

Price to Book Ratio vs Industry

How does KBLB's PB Ratio compare vs other companies in the US Chemicals Industry?

8 Companies	Price / Book	Estimated Growth	Market Cap
CGA Enlightify	0.3x	n/a	US$29.14m
DNMR Danimer Scientific	0.07x	35.2%	US$15.70m
GURE Gulf Resources	0.04x	n/a	US$6.65m
BON Bon Natural Life	0.2x	n/a	US$6.23m

8 Companies		Estimated Growth	Market Cap

No more companies

Price-To-Book vs Industry: KBLB has negative equity and a Price-To-Book Ratio (-7.4x) compared to the US Chemicals industry average (1.6x).

Price to Book Ratio vs Fair Ratio

What is KBLB's PB Ratio compared to its Fair PB Ratio? This is the expected PB Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

KBLB PB Ratio vs Fair Ratio.
Fair Ratio
Current PB Ratio	-7.4x
Fair PB Ratio	n/a

Price-To-Book vs Fair Ratio: Insufficient data to calculate KBLB's Price-To-Book Fair Ratio for valuation analysis.

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.

Discover undervalued companies

Chemtrade Logistics Income Fund

CA$1.4b

Offers industrial chemicals and services in Canada, the United States, and South America.

CGIF.F

CA$8.31

0.2%

28.8%

Mativ Holdings

US$716.7m

Manufactures and sells specialty materials in the United States, Europe, the Asia Pacific, the Americas, and internationally.

MATV

US$14.02

12.8%

14.2%

Eldorado Gold

CA$4.7b

Engages in the mining, exploration, development, and sale of mineral products primarily in Turkey, Canada, Greece, and Romania.

EGO

CA$15.69

-1.9%

28.0%